Author details

Full Name

Alexis Demopoulos

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33577785	Proteogenomic and metabolomic characterization of human glioblastoma.	Cancer Cell	2021
31631721	Primary Low-Grade B-Cell Lymphoma of Skull With Translocation Between Immunoglobulin and Interferon Regulatory Factor 4 Genes.	International Journal of Surgical Pathology	2020
31375115	Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatments.	BMC Med Genomics	2019
31023376	Sequencing and curation strategies for identifying candidate glioblastoma treatments.	BMC Med Genomics	2019
29790314	Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.	J Exp Ther Oncol	2018
26945581	Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.	J Neurooncol	2016
27270719	Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.	J Neurooncol	2016
26727654	Characterization of central nervous system multiple myeloma in the era of novel therapies.	Leukemia and Lymphoma	2016
26283762	Clinical Reasoning: Worsening neurologic symptoms in a brain tumor patient.	Neurology	2015
24847966	The successful treatment of a recurrent intracranial, dural-based plasmacytoma with lenalidomide.	Journal of Neuro-Oncology	2014
24810208	Nonconvulsive status epilepticus in patients with brain tumors.	Seizure : the journal of the British Epilepsy Association	2014
23098391	Central nervous system lymphoma in immunocompetent patients: the North Shore-Long Island Jewish Health System experience.	Journal of Clinical Neuroscience	2013
22005220	Neoplastic meningitis: challenging to diagnose, difficult to treat, important to palliate.	Journal of Supportive Oncology	2012
22277560	Normal or non-diagnostic neuroimaging studies prior to the detection of malignant primary brain tumors.	Journal of Clinical Neuroscience	2012
22076165	Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma.	International Journal of Clinical and Experimental Pathology (discontinued)	2011
20934264	A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.	Int J Radiat Oncol Biol Phys	2011
21626072	Leptomeningeal dissemination of anaplastic glioma: prolonged survival in two patients treated with temozolomide.	Journal of Neuro-Oncology	2011
21947537	Teaching NeuroImages: lymphomatoid granulomatosis involving lung and brain in an immunocompetent woman.	Neurology	2011
19618113	Primary CNS anaplastic diffuse large B-cell lymphoma mimicking undifferentiated metastatic tumors: a case report.	Journal of Neuro-Oncology	2010
18345516	Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.	Journal of Neuro-Oncology	2008
16614943	Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.	Journal of Neuro-Oncology	2006
16270316	Salvage temozolomide for prior temozolomide responders.	Cancer	2005
16211880	Anatomy and physiology of the leptomeninges and CSF space.	Cancer Treatment and Research	2005
15102345	Leptomeningeal metastases.	Current Neurology and Neuroscience Reports	2004
15365145	Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.	Neurology	2004
12447107	Neurologic complications of leukemia.	Current Opinion in Neurology	2002
11725181	The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy.	Journal of Neuro-Ophthalmology	2001
11493975	Hu Immunolabeling as a Marker of Neural and Neuroendocrine Differentiation in Normal and Neoplastic Human Tissues: Assessment Using a Recombinant Anti-Hu Fab Fragment.	International Journal of Surgical Pathology	2000